Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Single Center, Randomized Controlled Clinical Study of UCB (Cord Blood) in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)

NCT05577611 is registered in ClinicalTrials.gov with Zhongnan Hospital as lead sponsor.

NCT NCT05577611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05577611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Single Center, Randomized Controlled Clinical Study of UCB (Cord Blood) in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
Lead sponsor
Zhongnan Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
August 10, 2022
Completion date
December 25, 2024
Enrollment
57 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ucb (cord blood) microtransplantation in the treatment of newly diagnosed acute myeloid leukemia (aml)